Gene Delivery Technologies Market - Global Industry Analysis

Gene Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Technology & Media Report Format : PDF Report Code: ZMR-5885 Status : Upcoming

Description

Global Gene Delivery Technologies Market: Overview

The method of introducing foreign gene such as RNA or DNA into the host cells is called gene delivery. The process of gene delivery uses viral, chemical, or physical means for the introduction of the genetic material into the cells thus enhancing or amplifying their functions and harnessing their therapeutic potential. It utilizes non-immunogenic vectors that have the ability of cell specificity and can deliver an appropriate amount of transgene expression. Gene delivery technology is been used in gene therapy to deliver genetic material for the treatment of the disease.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Gene Delivery Technologies Market: Growth Factors

The global gene delivery technologies market is growing at a lucrative rate. Factors contributing to the growth of the global market include increasing research on advanced cell and gene therapies for the treatment of chronic diseases, growing investments in research & development activities by the public & private sector, and a growing focus on advanced gene delivery therapies by major players is primarily driving the growth of the global gene delivery technologies market. There is a wide range of gene delivery technologies such as viral transfection, cationic lipid transfection, electroporation, calcium phosphate transfection, and DEAE-dextran transfection which are used in the field of molecular biology for the development of new drugs. Further, developments in genomics have enabled several new methods and gene targets to be known for numerous applications. These and many other factors are contributing to the growth of the market. On the other hand, expensive methodology and high investment in research & product development may hamper the growth of the market over the forecast period. However, greater efficiency of gene delivery technologies to produce effective recombinant drugs will provide better growth opportunities to the market during the forecast period.

The rapid spread of Covid-19 has a multifaceted impact on the global gene delivery technologies market. The cell and gene therapy companies are particularly hit hard by the Covid-19 pandemic due to their complex manufacturing, delivery, and funding model. The Covid-19 crisis has disrupted the commercial operations, research & clinical development, and manufacture & delivery of treatments. The supply problems have also led to several problems. On the other hand, the government of several countries is providing funds and support to the large pharmaceuticals and biotechnology companies to develop a Covid-19 vaccine. Some of the major players signed an agreement for the manufacture of adenovirus vector-based vaccine for Covid-19. The pharmaceutical companies are bringing their development programs back on track. Thus, the global gene delivery technologies market experienced a steady growth rate during the pandemic.

Global Gene Delivery Technologies Market: Segmentation

The global gene delivery technologies market is classified based on application, mode, method, and region. Based on the application, the global gene delivery technologies market is fragmented into cell therapy, gene therapy, research, and vaccines. Based on the mode, the global market is segregated into chemical, biological, and physical. The method application is bifurcated into in vivo, ex vivo, and in vitro.

Global Gene Delivery Technologies Market: Regional Analysis

North America is expected to dominate the global gene delivery technologies market in terms of revenue over the forecast period. Factors that are contributing to the growth of the gene delivery technologies market in this region include the growing need for an advanced recombinant drug to treat chronic diseases, high investments in research & development by the public as well as the private sector, and presence of major biopharmaceuticals in this region. They are contributing to generate significant revenue in this region. Europe is expected to stay in the second position in the global gene delivery technologies market. However, the rapid growth of the market is expected in Asia Pacific region. Increasing investments in research & development in the field of life sciences, availability of skilled workforce in the region, and large local market for innovative drugs is expected to provide exponential growth opportunities to the market over the forecast period.

Global Gene Delivery Technologies Market: Competitive Players

The global gene delivery technologies market is highly competitive due to advancements in the technologies and adoption of gene delivery for the treatment of diseases. Some of the giant players in the global market are Hoffmann-La Roche AG, System Biosciences llc, Takara Bio Inc, SignaGen Laboratories, OriGene Technologies, Inc, QIAGEN, Thermo Fisher Scientific, Inc, Promega Corporation, Oxford Biomedica, and Horizon Discovery Group Co.

Global Gene Delivery Technologies Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Factors contributing to the growth of the global gene delivery technologies market include increasing research on advanced cell and gene therapies for the treatment of chronic diseases, growing investments in research and development activities by the public and private sector, and a growing focus on advanced gene delivery therapies by major players is majorly driving the growth of the global gene delivery technologies market. Furthermore, greater efficiency of gene delivery technologies to produce effective recombinant drugs will provide better growth opportunities to the market during the forecast period.

The global gene delivery technologies market is highly competitive due to advancements in the technologies and adoption of gene delivery for the treatment of diseases. Some of the giant players in the global market are Hoffmann-La Roche AG, System Biosciences llc, Takara Bio Inc, SignaGen Laboratories, OriGene Technologies, Inc, QIAGEN, Thermo Fisher Scientific, Inc, Promega Corporation, Oxford Biomedica, and Horizon Discovery Group Co.

North America is expected to dominate the global gene delivery technologies market in terms of revenue over the forecast period. Factors that are contributing to the growth of the gene delivery technologies market in this region include the growing need for an advanced recombinant drug to treat chronic diseases, high investments in research and development by the public as well as the private sector, and presence of major biopharmaceuticals in this region. They are contributing to generate significant revenue in this region.

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-52454
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-52454
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social